Advisory Panel Conflict Waivers To Stay; FDA Will Provide Clarity On Process
This article was originally published in The Tan Sheet
Executive Summary
FDA's plan for improving its advisory committee member selection process focuses on increasing the transparency and consistency of the existing process rather than an overhaul of its practices
You may also be interested in...
Advisory Committee Policy Allows Members With Financial Conflicts To Vote
FDA advisory committee participants with personal financial conflicts of interest may fully participate in committee meetings, according to the agency's latest conflict of interest policy
Advisory Committee Policy Allows Members With Financial Conflicts To Vote
FDA advisory committee participants with personal financial conflicts of interest may fully participate in committee meetings, according to the agency's latest conflict of interest policy
Advisory Committee Policy Allows Members With Financial Conflicts To Vote
FDA advisory committee participants with personal financial conflicts of interest may fully participate in committee meetings, according to the agency's latest conflict of interest policy